CDK4/6 inhibition sensitizes intracranial tumors to PD-1 blockade in preclinical models of brain metastasis. Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, et al. Clin Cancer Res 2023 Aug 23:CCR-23-0433. doi: 10.1158/1078-0432.CCR-23-0433.

Read + Share

Amedeo Smart

Independent Medical Education

Nayyar N, de Sauvage MA, Chuprin J, Sullivan EM, et al. CDK4/6 inhibition sensitizes intracranial tumors to PD-1 blockade in preclinical models of brain metastasis. Clin Cancer Res 2023 Aug 23:CCR-23-0433. doi: 10.1158/1078-0432.CCR-23-0433.
PMID: 37611074